Darryl Raymond Davis

Darryl Raymond Davis

Auto-generated profile, based on publicly available information

Darryl Raymond Davis

Division of Cardiology, Department of Medicine, University of Ottawa and University of Ottawa Heart Institute , H-1285D, 40 Ruskin St. Ottawa, Ottawa Ontario K1Y 4W7

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2004 in Journal of Clinical Epidemiology
Verified
Journal Article
Closed access
CWCarl van Walraven
Carl van Walraven
DDDarryl Davis
Darryl Davis
AFAlan J. Forster
Alan J. Forster
GWGeorge A. Wells
George A. Wells

25 September 2009 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DDDarryl R Davis
Darryl R Davis
YZYiqiang Zhang
Yiqiang Zhang
RSRachel R Smith
Rachel R Smith
KCKe Cheng
Ke Cheng
JTJohn Terrovitis
John Terrovitis
EMEduardo Marbán
Eduardo Marbán
At least four laboratories have shown that endogenous cardiac progenitor cells (CPCs) can be grown directly from adult heart tissue in primary culture, as cardiospheres or their progeny (cardiosphere-derived cells, CDCs). Indeed, CDCs are already being tested in a clinical trial for cardiac regeneration. Nevertheless, the validity of the cardiosphere strategy to generate CPCs has been called into question by reports based on variant methods. In those reports, cardiospheres are argued to be cardiomyogenic only because of retained cardiomyocytes, and stem cell activity has been proposed to reflect hematological contamination. We use a variety of approaches (including genetic lineage tracing) to show that neither artifact is applicable to cardiospheres and CDCs grown using established methods, and we further document the stem cell characteristics (namely, clonogenicity and multilineage potential) of CDCs. CPCs were expanded from human endomyocardial biopsies (n = 160), adult bi-transgenic MerCreMer-Z/EG mice (n = 6), adult C57BL/6 mice (n = 18), adult GFP+ C57BL/6 transgenic mice (n = 3), Yucatan mini pigs (n = 67), adult SCID beige mice (n = 8), and adult Wistar-Kyoto rats (n = 80). Cellular yield was enhanced by collagenase digestion and process standardization; yield was reduced in altered media and in specific animal strains. Heparinization/retrograde organ perfusion did not alter the ability to generate outgrowth from myocardial sample. The initial outgrowth from myocardial samples was enriched for sub-populations of CPCs (c-Kit+), endothelial cells (CD31+, CD34+), and mesenchymal cells (CD90+). Lineage tracing using MerCreMer-Z/EG transgenic mice revealed that the presence of cardiomyocytes in the cellular outgrowth is not required for the generation of CPCs. Rat CDCs are shown to be clonogenic, and cloned CDCs exhibit spontaneous multineage potential. This study demonstrates that direct culture and expansion of CPCs from myocardial tissue is simple, straightforward, and reproducible when appropriate techniques are used.

1 November 2010 in Stem Cells
Verified
Journal Article
Open access
PDF file
TLTao-Sheng Li
Tao-Sheng Li
KCKe Cheng
Ke Cheng
SLShuo-Tsan Lee
Shuo-Tsan Lee
SMSatoshi Matsushita
Satoshi Matsushita
DDDarryl Davis
Darryl Davis
EMEduardo Marbán
Eduardo Marbán
Cardiac stem cells (CSCs) are promising candidates for use in myocardial regenerative therapy. We test the hypothesis that growing cardiac-derived cells as three-dimensional cardiospheres may recapitulate a stem cell niche-like microenvironment, favoring cell survival and enhancing functional benefit after transplantation into the injured heart. CSCs and supporting cells from human endomyocardial biopsies were grown as cardiospheres and compared with cells cultured under traditional monolayer condition or dissociated from cardiospheres. Cardiospheres self-assembled into stem cell niche-like structures in vitro in suspension culture, while exhibiting greater proportions of c-kit+ cells and upregulated expression of SOX2 and Nanog. Pathway-focused polymerase chain reaction (PCR) array, quantitative real-time PCR, and immunostaining revealed enhanced expression of stem cell-relevant factors and adhesion/extracellular-matrix molecules (ECM) in cardiospheres including IGF-1, histone deacetylase 2 (HDAC2), Tert, integrin-α2, laminin-β1, and matrix metalloproteinases (MMPs). Implantation of cardiospheres in severe combined immunodeficiency (SCID) mouse hearts with acute infarction disproportionately improved cell engraftment and myocardial function, relative to monolayer-cultured cells. Dissociation of cardiospheres into single cells decreased the expression of ECM and adhesion molecules and undermined resistance to oxidative stress, negating the improved cell engraftment and functional benefit in vivo. Growth of cardiac-derived cells as cardiospheres mimics stem cell niche properties with enhanced “stemness” and expression of ECM and adhesion molecules. These changes underlie an increase in cell survival and more potent augmentation of global function following implantation into the infarcted heart.

1 June 2006 in The American Journal of Cardiology
Verified
Journal Article
Closed access
LMLisa M. Mielniczuk
Lisa M. Mielniczuk
KWKathryn Williams
Kathryn Williams
DDDarryl R. Davis
Darryl R. Davis
ATAnthony S.L. Tang
Anthony S.L. Tang
RLRobert Lemery
Robert Lemery
DBDavid H. Birnie
David H. Birnie

8 April 2010 in Circulation Research
Verified
Journal Article
Closed access
PDF file
KCKe Cheng
Ke Cheng
TLTao-Sheng Li
Tao-Sheng Li
KMKonstantinos Malliaras
Konstantinos Malliaras
DDDarryl R. Davis
Darryl R. Davis
YZYiqiang Zhang
Yiqiang Zhang
EMEduardo Marbán
Eduardo Marbán
Rationale : The success of cardiac stem cell therapies is limited by low cell retention, due at least in part to washout via coronary veins. Objective : We sought to counter the efflux of transplanted cells by rendering them magnetically responsive and imposing an external magnetic field on the heart during and immediately after injection. Methods and Results : Cardiosphere-derived cells (CDCs) were labeled with superparamagnetic microspheres (SPMs). In vitro studies revealed that cell viability and function were minimally affected by SPM labeling. SPM-labeled rat CDCs were injected intramyocardially, with and without a superimposed magnet. With magnetic targeting, cells were visibly attracted toward the magnet and accumulated around the ischemic zone. In contrast, the majority of nontargeted cells washed out immediately after injection. Fluorescence imaging revealed more retention of transplanted cells in the heart, and less migration into other organs, in the magnetically targeted group. Quantitative PCR confirmed that magnetic targeting enhanced cell retention (at 24 hours) and engraftment (at 3 weeks) in the recipient hearts by ≈3-fold compared to nontargeted cells. Morphometric analysis revealed maximal attenuation of left ventricular remodeling, and echocardiography showed the greatest functional improvement, in the magnetic targeting group. Histologically, more engrafted cells were evident with magnetic targeting, but there was no incremental inflammation. Conclusions : Magnetic targeting enhances cell retention, engraftment and functional benefit. This novel method to improve cell therapy outcomes offers the potential for rapid translation into clinical applications.

1 March 2016 in JACC
Verified
Journal Article
Closed access
VEVidal Essebag
Vidal Essebag
AVAtul Verma
Atul Verma
JHJeff S. Healey
Jeff S. Healey
AKAndrew D. Krahn
Andrew D. Krahn
EKEli Kalfon
Eli Kalfon
JRJuliane Rodrigues
Juliane Rodrigues